Biofrontera Inc. (BFRI)
After hours:
- Simply Wall St.
When Will Biofrontera Inc. (NASDAQ:BFRI) Become Profitable?
We feel now is a pretty good time to analyse Biofrontera Inc.'s ( NASDAQ:BFRI ) business as it appears the company may...
- GlobeNewswire
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp
The RhodoLED XL is approved by the FDA in combination with Ameluz® (aminolevulinic acid hydrochloride) topical gel, 10% for photodynamic therapy (PDT) of actinic keratoses of mild-to-moderate severity on the face and scalpBiofrontera launched the commercial distribution of the RhodoLED XL on June 10, 2024, shipping the first three machines within 1 week of launch WOBURN, MA, June 24, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI), a biopharmaceutical company specializing in the commerc
- ACCESSWIRE
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
Conference call begins at 10:00 a.m. Eastern time on Thursday, May 16, 2024 WOBURN, MA / ACCESSWIRE / May 15, 2024 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic ...
